Congestive heart failure myocardial viability study: Difference between revisions
Jump to navigation
Jump to search
Line 43: | Line 43: | ||
==Vote on and Suggest Revisions to the Current Guidelines== | ==Vote on and Suggest Revisions to the Current Guidelines== | ||
*[[The Living Guidelines: Diagnosis and Management of Chronic Heart Failure | The CHF Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines]] | *[[The Living Guidelines: Diagnosis and Management of Chronic Heart Failure | The CHF Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines]] | ||
==References== | ==References== |
Revision as of 06:10, 10 February 2022
Resident Survival Guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
Overview
Myocardial viability studies can determine whether hypocontractile myocardium is viable but just hibernating, and could therefore benefit from revascularization.
Myocardial Viability Studies
Common imaging modalities to assess myocardial viability include:
- Dobutamine echocardiography
- Nuclear tests (SPECT or PET)
- Cardiac MRI
Class IIb |
"Non-invasive stress imaging (CMR, stress echocardiography, SPECT, PET) may be considered for the assessment of myocardial ischemia and viability in patients with CAD who are considered suitable for coronary revascularization. (Level of Evidence: B) " |
". Exercise testing may be considered to detect reversible myocardial ischemia and investigate the cause of dyspnea(Level of Evidence: C) " |
The above table adopted from 2021 ESC Guideline |
---|
Related Chapters
Vote on and Suggest Revisions to the Current Guidelines
References
- ↑ McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland J, Coats A, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam C, Lyon AR, McMurray J, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano G, Ruschitzka F, Kathrine Skibelund A (September 2021). "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure". Eur Heart J. 42 (36): 3599–3726. doi:10.1093/eurheartj/ehab368. PMID 34447992 Check
|pmid=
value (help). Vancouver style error: initials (help)